Corning Products Help MEARY Center Paris Advance Personalized Medicine

Dr. Guillaume Churlaud and his team produce cell and gene therapies, such as mesenchymal stromal cells, Treg lymphocytes, CAR-T cells, NK cells, and other ATMPs. All ATMPs produced in the MEARY Center are for phase 1 and 2 clinical trials. They produce new cells and new gene therapy drugs to treat patients suffering from autoimmune, hematological, and cardiac diseases, and so much more.

MEARY Center is the Paris University Hospitals Consortium’s core facility for cell and gene therapy. It is dedicated to the manufacturing of Advanced Therapy Medicinal Products (ATMPs) for the 39 leading university hospitals belonging to AP-HP. They are doing personalized medicine because in some cases they are treating the patient with its own cells. They take the cells of the patient; we modify the cells and then reinject these cells to the same patient in order to cure disease. For instance, they use autologous T cells to produce CAR-T cells, and then reinject these cells to the patient to treat its leukemia.

Continue reading to learn more on the tools they are using to isolate and expand mesenchymal stromal cells.